These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 15794796)

  • 1. The effect on erectile function of 103palladium implantation for localized prostate cancer.
    Ponholzer A; Oismüller R; Somay C; Büchler F; Maier U; Hawliczek R; Rauchenwald M; Madersbacher S
    BJU Int; 2005 Apr; 95(6):847-50. PubMed ID: 15794796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erectile function after brachytherapy with external beam radiation for prostate cancer.
    Fujioka H; Ishimura T; Sakai Y; Fujii T; Jo Y; Takenaka A; Fujisawa M
    Arch Androl; 2004; 50(4):295-301. PubMed ID: 15277008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An analysis of erectile function after intensity modulated radiation therapy for localized prostate carcinoma.
    Brown MW; Brooks JP; Albert PS; Poggi MM
    Prostate Cancer Prostatic Dis; 2007; 10(2):189-93. PubMed ID: 17189954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary symptom flare after brachytherapy for prostate cancer is associated with erectile dysfunction and more urinary symptoms before implantation.
    Lehrer S; Cesaretti J; Stone NN; Stock RG
    BJU Int; 2006 Nov; 98(5):979-81. PubMed ID: 17034599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The chronological process of erectile function after low-dose rate prostate brachytherapy for localised prostate cancer].
    Bannowsky A; Bäurle L; Ataniyasov R; Ahlen Hv; Loch T
    Aktuelle Urol; 2011 Jul; 42(4):252-5. PubMed ID: 21769761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Undetectable prostate specific antigen at 6-12 months: a new marker for early success in hormonally treated patients after prostate brachytherapy.
    Miller N; Smolkin ME; Bissonette E; Theodorescu D
    Cancer; 2005 Jun; 103(12):2499-506. PubMed ID: 15852361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sexual function after permanent 125I-brachytherapy for prostate cancer.
    Mabjeesh N; Chen J; Beri A; Stenger A; Matzkin H
    Int J Impot Res; 2005; 17(1):96-101. PubMed ID: 15510186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of low dose-rate prostate brachytherapy on the sexual health of men with optimal sexual function before treatment: analysis at > or = 7 years of follow-up.
    Cesaretti JA; Kao J; Stone NN; Stock RG
    BJU Int; 2007 Aug; 100(2):362-7. PubMed ID: 17617140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of erectile dysfunction among Brazilian men screened for prostate cancer.
    Paranhos M; Antunes A; Andrade E; Freire G; Srougi M
    BJU Int; 2009 Oct; 104(8):1130-3. PubMed ID: 19426190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erectile function durability following permanent prostate brachytherapy.
    Taira AV; Merrick GS; Galbreath RW; Butler WM; Wallner KE; Kurko BS; Anderson R; Lief JH
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):639-48. PubMed ID: 19303721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Success of sildenafil for erectile dysfunction in men treated with brachytherapy or external beam radiation for prostate cancer.
    Shemtov OM; Radomski SB; Crook J
    Can J Urol; 2004 Dec; 11(6):2450-5. PubMed ID: 15636671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early use of a phosphodiesterase inhibitor after brachytherapy restores and preserves erectile function.
    Schiff JD; Bar-Chama N; Cesaretti J; Stock R
    BJU Int; 2006 Dec; 98(6):1255-8. PubMed ID: 17125483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erectile function after permanent prostate brachytherapy.
    Merrick GS; Butler WM; Galbreath RW; Stipetich RL; Abel LJ; Lief JH
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):893-902. PubMed ID: 11958881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of sildenafil citrate following radiation therapy for prostate cancer: temporal considerations.
    Ohebshalom M; Parker M; Guhring P; Mulhall JP
    J Urol; 2005 Jul; 174(1):258-62; discussion 262. PubMed ID: 15947650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the impact of androgen deprivation therapy on sildenafil citrate response following radiation therapy for prostate cancer.
    Teloken PE; Ohebshalom M; Mohideen N; Mulhall JP
    J Urol; 2007 Dec; 178(6):2521-5. PubMed ID: 17937948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term potency preservation following brachytherapy for prostate cancer.
    Snyder KM; Stock RG; Buckstein M; Stone NN
    BJU Int; 2012 Jul; 110(2):221-5. PubMed ID: 22734475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erectile function after prostate brachytherapy.
    Merrick GS; Butler WM; Wallner KE; Galbreath RW; Anderson RL; Kurko BS; Lief JH; Allen ZA
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):437-47. PubMed ID: 15890585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining sexual outcomes after treatment for localized prostate carcinoma.
    Schover LR; Fouladi RT; Warneke CL; Neese L; Klein EA; Zippe C; Kupelian PA
    Cancer; 2002 Oct; 95(8):1773-85. PubMed ID: 12365027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvage prostate brachytherapy for localized prostate cancer failure after external beam radiation therapy.
    Lee HK; Adams MT; Motta J
    Brachytherapy; 2008; 7(1):17-21. PubMed ID: 18201939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Penile erectile function after permanent radioactive seed implantation for treatment of prostate cancer.
    Stock RG; Kao J; Stone NN
    J Urol; 2001 Feb; 165(2):436-9. PubMed ID: 11176391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.